Page last updated: 2024-11-06

thyroxine and Retinal Diseases

thyroxine has been researched along with Retinal Diseases in 2 studies

Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.

Retinal Diseases: Diseases involving the RETINA.

Research Excerpts

ExcerptRelevanceReference
"A Graves' disease was diagnosed and the patient was initially controlled with antithyroid drugs."1.31[Acute posterior multifocal placoid pigment epitheliopathy associated with Graves-Basedow's disease]. ( Buil Calvo, JA; Castilla Céspedes, M; Martínez Giralto, O; Ruiz Viñals, AT, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Peng, PH1
Chao, HM1
Juan, SH1
Chen, CF1
Liu, JH1
Ko, ML1
Ruiz Viñals, AT1
Buil Calvo, JA1
Martínez Giralto, O1
Castilla Céspedes, M1

Other Studies

2 other studies available for thyroxine and Retinal Diseases

ArticleYear
Pharmacological preconditioning by low dose cobalt protoporphyrin induces heme oxygenase-1 overexpression and alleviates retinal ischemia-reperfusion injury in rats.
    Current eye research, 2011, Volume: 36, Issue:3

    Topics: Alanine Transaminase; Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Female; Hem

2011
[Acute posterior multifocal placoid pigment epitheliopathy associated with Graves-Basedow's disease].
    Archivos de la Sociedad Espanola de Oftalmologia, 2002, Volume: 77, Issue:7

    Topics: Acute Disease; Adult; Antithyroid Agents; Choroid; Combined Modality Therapy; Female; Fluorescein An

2002